1258 lines
256 KiB
CSV
1258 lines
256 KiB
CSV
|
token_id,label_code,label_name,hfrs_dimension_id,hfrs_dimension,hfrs_key_area,hfrs_weight,hfrs_source,match_source
|
||
|
|
3,A00,(cholera),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
4,A01,(typhoid and paratyphoid fevers),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
5,A02,(other salmonella infections),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
6,A03,(shigellosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
7,A04,(other bacterial intestinal infections),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.1,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
8,A05,(other bacterial foodborne intoxications),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
9,A06,(amoebiasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
10,A07,(other protozoal intestinal diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
11,A08,(viral and other specified intestinal infections),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
12,A09,(diarrhoea and gastro-enteritis of presumed infectious origin),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.1,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
13,A15,"(respiratory tuberculosis, bacteriologically and histologically confirmed)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
14,A16,"(respiratory tuberculosis, not confirmed bacteriologically or histologically)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
15,A17,(tuberculosis of nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
16,A18,(tuberculosis of other organs),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
17,A19,(miliary tuberculosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
18,A20,(plague),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
19,A22,(anthrax),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
20,A23,(brucellosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
21,A24,(glanders and melioidosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
22,A25,(rat-bite fevers),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
23,A26,(erysipeloid),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
24,A27,(leptospirosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
25,A28,"(other zoonotic bacterial diseases, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
26,A30,(leprosy [hansen's disease]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
27,A31,(infection due to other mycobacteria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
28,A32,(listeriosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
29,A33,(tetanus neonatorum),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
30,A35,(other tetanus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
31,A36,(diphtheria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
32,A37,(whooping cough),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
33,A38,(scarlet fever),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
34,A39,(meningococcal infection),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
35,A40,(streptococcal septicaemia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
36,A41,(other septicaemia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.6,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
37,A42,(actinomycosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
38,A43,(nocardiosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
39,A44,(bartonellosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
40,A46,(erysipelas),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
41,A48,"(other bacterial diseases, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
42,A49,(bacterial infection of unspecified site),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
43,A50,(congenital syphilis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
44,A51,(early syphilis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
45,A52,(late syphilis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
46,A53,(other and unspecified syphilis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
47,A54,(gonococcal infection),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
48,A55,(chlamydial lymphogranuloma (venereum)),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
49,A56,(other sexually transmitted chlamydial diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
50,A58,(granuloma inguinale),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
51,A59,(trichomoniasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
52,A60,(anogenital herpesviral [herpes simplex] infections),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
53,A63,"(other predominantly sexually transmitted diseases, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
54,A64,(unspecified sexually transmitted disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
55,A66,(yaws),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
56,A67,(pinta [carate]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
57,A68,(relapsing fevers),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
58,A69,(other spirochaetal infections),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
59,A70,(chlamydia psittaci infection),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
60,A71,(trachoma),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
61,A74,(other diseases caused by chlamydiae),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
62,A75,(typhus fever),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
63,A77,(spotted fever [tick-borne rickettsioses]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
64,A78,(q fever),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
65,A79,(other rickettsioses),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
66,A80,(acute poliomyelitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
67,A81,(atypical virus infections of central nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
68,A82,(rabies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
69,A83,(mosquito-borne viral encephalitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
70,A84,(tick-borne viral encephalitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
71,A85,"(other viral encephalitis, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
72,A86,(unspecified viral encephalitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
73,A87,(viral meningitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
74,A88,"(other viral infections of central nervous system, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
75,A89,(unspecified viral infection of central nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
76,A90,(dengue fever [classical dengue]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
77,A91,(dengue haemorrhagic fever),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
78,A92,(other mosquito-borne viral fevers),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
79,A93,"(other arthropod-borne viral fevers, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
80,A94,(unspecified arthropod-borne viral fever),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
81,A95,(yellow fever),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
82,A97,(dengue),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
83,A98,"(other viral haemorrhagic fevers, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
84,B00,(herpesviral [herpes simplex] infections),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
85,B01,(varicella [chickenpox]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
86,B02,(zoster [herpes zoster]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
87,B03,(smallpox),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
88,B05,(measles),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
89,B06,(rubella [german measles]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
90,B07,(viral warts),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
91,B08,"(other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
92,B09,(unspecified viral infection characterised by skin and mucous membrane lesions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
93,B15,(acute hepatitis a),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
94,B16,(acute hepatitis b),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
95,B17,(other acute viral hepatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
96,B18,(chronic viral hepatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
97,B19,(unspecified viral hepatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
98,B20,(human immunodeficiency virus [hiv] disease resulting in infectious and parasitic diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
99,B21,(human immunodeficiency virus [hiv] disease resulting in malignant neoplasms),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
100,B22,(human immunodeficiency virus [hiv] disease resulting in other specified diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
101,B23,(human immunodeficiency virus [hiv] disease resulting in other conditions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
102,B24,(unspecified human immunodeficiency virus [hiv] disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
103,B25,(cytomegaloviral disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
104,B26,(mumps),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
105,B27,(infectious mononucleosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
106,B30,(viral conjunctivitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
107,B33,"(other viral diseases, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
108,B34,(viral infection of unspecified site),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
109,B35,(dermatophytosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
110,B36,(other superficial mycoses),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
111,B37,(candidiasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
112,B38,(coccidioidomycosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
113,B39,(histoplasmosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
114,B40,(blastomycosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
115,B42,(sporotrichosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
116,B43,(chromomycosis and phaeomycotic abscess),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
117,B44,(aspergillosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
118,B45,(cryptococcosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
119,B46,(zygomycosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
120,B47,(mycetoma),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
121,B48,"(other mycoses, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
122,B49,(unspecified mycosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
123,B50,(plasmodium falciparum malaria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
124,B51,(plasmodium vivax malaria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
125,B52,(plasmodium malariae malaria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
126,B53,(other parasitologically confirmed malaria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
127,B54,(unspecified malaria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
128,B55,(leishmaniasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
129,B57,(chagas' disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
130,B58,(toxoplasmosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
131,B59,(pneumocystosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
132,B60,"(other protozoal diseases, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
133,B65,(schistosomiasis [bilharziasis]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
134,B66,(other fluke infections),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
135,B67,(echinococcosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
136,B68,(taeniasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
137,B69,(cysticercosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
138,B71,(other cestode infections),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
139,B73,(onchocerciasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
140,B74,(filariasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
141,B75,(trichinellosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
142,B76,(hookworm diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
143,B77,(ascariasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
144,B78,(strongyloidiasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
145,B79,(trichuriasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
146,B80,(enterobiasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
147,B81,"(other intestinal helminthiases, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
148,B82,(unspecified intestinal parasitism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
149,B83,(other helminthiases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
150,B85,(pediculosis and phthiriasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
151,B86,(scabies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
152,B87,(myiasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
153,B88,(other infestations),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
154,B89,(unspecified parasitic disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
155,B90,(sequelae of tuberculosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
156,B91,(sequelae of poliomyelitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
157,B94,(sequelae of other and unspecified infectious and parasitic diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
158,B95,(streptococcus and staphylococcus as the cause of diseases classified to other chapters),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.7,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
159,B96,(other bacterial agents as the cause of diseases classified to other chapters),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,2.9,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
160,B97,(viral agents as the cause of diseases classified to other chapters),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
161,B98,(other specified infectious agents as the cause of diseases classified to other chapters),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
162,B99,(other and unspecified infectious diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
163,D50,(iron deficiency anaemia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
164,D51,(vitamin b12 deficiency anaemia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
165,D52,(folate deficiency anaemia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
166,D53,(other nutritional anaemias),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
167,D55,(anaemia due to enzyme disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
168,D56,(thalassaemia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
169,D57,(sickle-cell disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
170,D58,(other hereditary haemolytic anaemias),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
171,D59,(acquired haemolytic anaemia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
172,D60,(acquired pure red cell aplasia [erythroblastopenia]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
173,D61,(other aplastic anaemias),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
174,D62,(acute posthaemorrhagic anaemia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
175,D63,(anaemia in chronic diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
176,D64,(other anaemias),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.4,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
177,D65,(disseminated intravascular coagulation [defibrination syndrome]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
178,D66,(hereditary factor viii deficiency),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
179,D67,(hereditary factor ix deficiency),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
180,D68,(other coagulation defects),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
181,D69,(purpura and other haemorrhagic conditions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
182,D70,(agranulocytosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
183,D71,(functional disorders of polymorphonuclear neutrophils),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
184,D72,(other disorders of white blood cells),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
185,D73,(diseases of spleen),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
186,D74,(methaemoglobinaemia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
187,D75,(other diseases of blood and blood-forming organs),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
188,D76,(certain diseases involving lymphoreticular tissue and reticulohistiocytic system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
189,D77,(other disorders of blood and blood-forming organs in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
190,D80,(immunodeficiency with predominantly antibody defects),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
191,D81,(combined immunodeficiencies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
192,D82,(immunodeficiency associated with other major defects),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
193,D83,(common variable immunodeficiency),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
194,D84,(other immunodeficiencies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
195,D86,(sarcoidosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
196,D89,"(other disorders involving the immune mechanism, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
197,E01,(iodine-deficiency-related thyroid disorders and allied conditions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
198,E02,(subclinical iodine-deficiency hypothyroidism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
199,E03,(other hypothyroidism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
200,E04,(other non-toxic goitre),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
201,E05,(thyrotoxicosis [hyperthyroidism]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.9,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
202,E06,(thyroiditis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
203,E07,(other disorders of thyroid),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
204,E10,(insulin-dependent diabetes mellitus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
205,E11,(non-insulin-dependent diabetes mellitus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
206,E12,(malnutrition-related diabetes mellitus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
207,E13,(other specified diabetes mellitus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
208,E14,(unspecified diabetes mellitus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
209,E15,(nondiabetic hypoglycaemic coma),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
210,E16,(other disorders of pancreatic internal secretion),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.4,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
211,E20,(hypoparathyroidism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
212,E21,(hyperparathyroidism and other disorders of parathyroid gland),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
213,E22,(hyperfunction of pituitary gland),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
214,E23,(hypofunction and other disorders of pituitary gland),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
215,E24,(cushing's syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
216,E25,(adrenogenital disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
217,E26,(hyperaldosteronism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
218,E27,(other disorders of adrenal gland),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
219,E28,(ovarian dysfunction),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
220,E29,(testicular dysfunction),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
221,E30,"(disorders of puberty, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
222,E31,(polyglandular dysfunction),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
223,E32,(diseases of thymus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
224,E34,(other endocrine disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
225,E35,(disorders of endocrine glands in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
226,E41,(nutritional marasmus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
227,E43,(unspecified severe protein-energy malnutrition),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
228,E44,(protein-energy malnutrition of moderate and mild degree),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
229,E45,(retarded development following protein-energy malnutrition),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
230,E46,(unspecified protein-energy malnutrition),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
231,E50,(vitamin a deficiency),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
232,E51,(thiamine deficiency),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
233,E52,(niacin deficiency [pellagra]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
234,E53,(deficiency of other b group vitamins),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.9,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
235,E54,(ascorbic acid deficiency),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
236,E55,(vitamin d deficiency),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
237,E56,(other vitamin deficiencies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
238,E58,(dietary calcium deficiency),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
239,E59,(dietary selenium deficiency),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
240,E60,(dietary zinc deficiency),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
241,E61,(deficiency of other nutrient elements),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
242,E63,(other nutritional deficiencies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
243,E64,(sequelae of malnutrition and other nutritional deficiencies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
244,E65,(localised adiposity),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
245,E66,(obesity),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
246,E67,(other hyperalimentation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
247,E68,(sequelae of hyperalimentation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
248,E70,(disorders of aromatic amino-acid metabolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
249,E71,(disorders of branched-chain amino-acid metabolism and fatty-acid metabolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
250,E72,(other disorders of amino-acid metabolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
251,E73,(lactose intolerance),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
252,E74,(other disorders of carbohydrate metabolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
253,E75,(disorders of sphingolipid metabolism and other lipid storage disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
254,E76,(disorders of glycosaminoglycan metabolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
255,E77,(disorders of glycoprotein metabolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
256,E78,(disorders of lipoprotein metabolism and other lipidaemias),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
257,E79,(disorders of purine and pyrimidine metabolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
258,E80,(disorders of porphyrin and bilirubin metabolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
259,E83,(disorders of mineral metabolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.4,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
260,E84,(cystic fibrosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
261,E85,(amyloidosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
262,E86,(volume depletion),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,2.3,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
263,E87,"(other disorders of fluid, electrolyte and acid-base balance)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,2.3,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
264,E88,(other metabolic disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
265,E89,"(postprocedural endocrine and metabolic disorders, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
266,F00,(dementia in alzheimer's disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,7.1,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
267,F01,(vascular dementia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,2.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
268,F02,(dementia in other diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
269,F03,(unspecified dementia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,2.1,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
270,F04,"(organic amnesic syndrome, not induced by alcohol and other psychoactive substances)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
271,F05,"(delirium, not induced by alcohol and other psychoactive substances)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,3.2,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
272,F06,(other mental disorders due to brain damage and dysfunction and to physical disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
273,F07,"(personality and behavioural disorders due to brain disease, damage and dysfunction)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
274,F09,(unspecified organic or symptomatic mental disorder),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
275,F10,(mental and behavioural disorders due to use of alcohol),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.7,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
276,F11,(mental and behavioural disorders due to use of opioids),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
277,F12,(mental and behavioural disorders due to use of cannabinoids),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
278,F13,(mental and behavioural disorders due to use of sedatives or hypnotics),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
279,F14,(mental and behavioural disorders due to use of cocaine),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
280,F15,"(mental and behavioural disorders due to use of other stimulants, including caffeine)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
281,F16,(mental and behavioural disorders due to use of hallucinogens),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
282,F17,(mental and behavioural disorders due to use of tobacco),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
283,F18,(mental and behavioural disorders due to use of volatile solvents),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
284,F19,(mental and behavioural disorders due to multiple drug use and use of other psychoactive substances),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
285,F20,(schizophrenia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
286,F21,(schizotypal disorder),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
287,F22,(persistent delusional disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
288,F23,(acute and transient psychotic disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
289,F24,(induced delusional disorder),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
290,F25,(schizoaffective disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
291,F28,(other nonorganic psychotic disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
292,F29,(unspecified nonorganic psychosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
293,F30,(manic episode),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
294,F31,(bipolar affective disorder),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
295,F32,(depressive episode),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.5,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
296,F33,(recurrent depressive disorder),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
297,F34,(persistent mood [affective] disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
298,F38,(other mood [affective] disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
299,F39,(unspecified mood [affective] disorder),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
300,F40,(phobic anxiety disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
301,F41,(other anxiety disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
302,F42,(obsessive-compulsive disorder),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
303,F43,"(reaction to severe stress, and adjustment disorders)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
304,F44,(dissociative [conversion] disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
305,F45,(somatoform disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
306,F48,(other neurotic disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
307,F50,(eating disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
308,F51,(nonorganic sleep disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
309,F52,"(sexual dysfunction, not caused by organic disorder or disease)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
310,F53,"(mental and behavioural disorders associated with the puerperium, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
311,F54,(psychological and behavioural factors associated with disorders or diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
312,F55,(abuse of non-dependence-producing substances),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
313,F59,(unspecified behavioural syndromes associated with physiological disturbances and physical factors),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
314,F60,(specific personality disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
315,F61,(mixed and other personality disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
316,F62,"(enduring personality changes, not attributable to brain damage and disease)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
317,F63,(habit and impulse disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
318,F64,(gender identity disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
319,F65,(disorders of sexual preference),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
320,F66,(psychological and behavioural disorders associated with sexual development and orientation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
321,F68,(other disorders of adult personality and behaviour),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
322,F69,(unspecified disorder of adult personality and behaviour),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
323,F70,(mild mental retardation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
324,F71,(moderate mental retardation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
325,F72,(severe mental retardation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
326,F78,(other mental retardation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
327,F79,(unspecified mental retardation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
328,F80,(specific developmental disorders of speech and language),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
329,F81,(specific developmental disorders of scholastic skills),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
330,F82,(specific developmental disorder of motor function),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
331,F83,(mixed specific developmental disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
332,F84,(pervasive developmental disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
333,F88,(other disorders of psychological development),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
334,F89,(unspecified disorder of psychological development),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
335,F90,(hyperkinetic disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
336,F91,(conduct disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
337,F92,(mixed disorders of conduct and emotions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
338,F93,(emotional disorders with onset specific to childhood),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
339,F94,(disorders of social functioning with onset specific to childhood and adolescence),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
340,F95,(tic disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
341,F98,(other behavioural and emotional disorders with onset usually occurring in childhood and adolescence),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
342,F99,"(mental disorder, not otherwise specified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
343,G00,"(bacterial meningitis, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
344,G01,(meningitis in bacterial diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
345,G02,(meningitis in other infectious and parasitic diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
346,G03,(meningitis due to other and unspecified causes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
347,G04,"(encephalitis, myelitis and encephalomyelitis)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
348,G05,"(encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
349,G06,(intracranial and intraspinal abscess and granuloma),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
350,G07,(intracranial and intraspinal abscess and granuloma in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
351,G08,(intracranial and intraspinal phlebitis and thrombophlebitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
352,G09,(sequelae of inflammatory diseases of central nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
353,G10,(huntington's disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
354,G11,(hereditary ataxia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
355,G12,(spinal muscular atrophy and related syndromes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
356,G13,(systemic atrophies primarily affecting central nervous system in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
357,G14,(postpolio syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
358,G20,(parkinson's disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.8,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
359,G21,(secondary parkinsonism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
360,G22,(parkinsonism in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
361,G23,(other degenerative diseases of basal ganglia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
362,G24,(dystonia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
363,G25,(other extrapyramidal and movement disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
364,G30,(alzheimer's disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,4.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
365,G31,"(other degenerative diseases of nervous system, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.2,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
366,G32,(other degenerative disorders of nervous system in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
367,G35,(multiple sclerosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
368,G36,(other acute disseminated demyelination),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
369,G37,(other demyelinating diseases of central nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
370,G40,(epilepsy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.5,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
371,G41,(status epilepticus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
372,G43,(migraine),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
373,G44,(other headache syndromes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
374,G45,(transient cerebral ischaemic attacks and related syndromes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.2,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
375,G46,(vascular syndromes of brain in cerebrovascular diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
376,G47,(sleep disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
377,G50,(disorders of trigeminal nerve),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
378,G51,(facial nerve disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
379,G52,(disorders of other cranial nerves),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
380,G53,(cranial nerve disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
381,G54,(nerve root and plexus disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
382,G55,(nerve root and plexus compressions in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
383,G56,(mononeuropathies of upper limb),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
384,G57,(mononeuropathies of lower limb),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
385,G58,(other mononeuropathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
386,G59,(mononeuropathy in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
387,G60,(hereditary and idiopathic neuropathy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
388,G61,(inflammatory polyneuropathy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
389,G62,(other polyneuropathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
390,G63,(polyneuropathy in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
391,G64,(other disorders of peripheral nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
392,G70,(myasthenia gravis and other myoneural disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
393,G71,(primary disorders of muscles),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
394,G72,(other myopathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
395,G73,(disorders of myoneural junction and muscle in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
396,G80,(infantile cerebral palsy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
397,G81,(hemiplegia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,4.4,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
398,G82,(paraplegia and tetraplegia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
399,G83,(other paralytic syndromes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
400,G90,(disorders of autonomic nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
401,G91,(hydrocephalus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
402,G92,(toxic encephalopathy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
403,G93,(other disorders of brain),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
404,G94,(other disorders of brain in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
405,G95,(other diseases of spinal cord),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
406,G96,(other disorders of central nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
407,G97,"(postprocedural disorders of nervous system, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
408,G98,"(other disorders of nervous system, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
409,G99,(other disorders of nervous system in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
410,H00,(hordeolum and chalazion),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
411,H01,(other inflammation of eyelid),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
412,H02,(other disorders of eyelid),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
413,H03,(disorders of eyelid in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
414,H04,(disorders of lachrymal system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
415,H05,(disorders of orbit),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
416,H06,(disorders of lachrymal system and orbit in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
417,H10,(conjunctivitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
418,H11,(other disorders of conjunctiva),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
419,H13,(disorders of conjunctiva in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
420,H15,(disorders of sclera),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
421,H16,(keratitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
422,H17,(corneal scars and opacities),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
423,H18,(other disorders of cornea),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
424,H19,(disorders of sclera and cornea in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
425,H20,(iridocyclitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
426,H21,(other disorders of iris and ciliary body),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
427,H22,(disorders of iris and ciliary body in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
428,H25,(senile cataract),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
429,H26,(other cataract),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
430,H27,(other disorders of lens),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
431,H28,(cataract and other disorders of lens in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
432,H30,(chorioretinal inflammation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
433,H31,(other disorders of choroid),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
434,H32,(chorioretinal disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
435,H33,(retinal detachments and breaks),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
436,H34,(retinal vascular occlusions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
437,H35,(other retinal disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
438,H36,(retinal disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
439,H40,(glaucoma),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
440,H42,(glaucoma in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
441,H43,(disorders of vitreous body),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
442,H44,(disorders of globe),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
443,H45,(disorders of vitreous body and globe in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
444,H46,(optic neuritis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
445,H47,(other disorders of optic [2nd] nerve and visual pathways),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
446,H48,(disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
447,H49,(paralytic strabismus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
448,H50,(other strabismus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
449,H51,(other disorders of binocular movement),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
450,H52,(disorders of refraction and accommodation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
451,H53,(visual disturbances),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
452,H54,(blindness and low vision),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.9,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
453,H55,(nystagmus and other irregular eye movements),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
454,H57,(other disorders of eye and adnexa),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
455,H58,(other disorders of eye and adnexa in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
456,H59,"(postprocedural disorders of eye and adnexa, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
457,H60,(otitis externa),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
458,H61,(other disorders of external ear),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
459,H62,(disorders of external ear in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
460,H65,(nonsuppurative otitis media),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
461,H66,(suppurative and unspecified otitis media),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
462,H67,(otitis media in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
463,H68,(eustachian salpingitis and obstruction),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
464,H69,(other disorders of eustachian tube),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
465,H70,(mastoiditis and related conditions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
466,H71,(cholesteatoma of middle ear),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
467,H72,(perforation of tympanic membrane),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
468,H73,(other disorders of tympanic membrane),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
469,H74,(other disorders of middle ear and mastoid),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
470,H75,(other disorders of middle ear and mastoid in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
471,H80,(otosclerosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
472,H81,(disorders of vestibular function),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
473,H82,(vertiginous syndromes in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
474,H83,(other diseases of inner ear),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
475,H90,(conductive and sensorineural hearing loss),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
476,H91,(other hearing loss),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.9,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
477,H92,(otalgia and effusion of ear),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
478,H93,"(other disorders of ear, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
479,H94,(other disorders of ear in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
480,H95,"(postprocedural disorders of ear and mastoid process, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
481,I00,(rheumatic fever without mention of heart involvement),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
482,I01,(rheumatic fever with heart involvement),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
483,I02,(rheumatic chorea),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
484,I05,(rheumatic mitral valve diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
485,I06,(rheumatic aortic valve diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
486,I07,(rheumatic tricuspid valve diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
487,I08,(multiple valve diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
488,I09,(other rheumatic heart diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
489,I10,(essential (primary) hypertension),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
490,I11,(hypertensive heart disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
491,I12,(hypertensive renal disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
492,I13,(hypertensive heart and renal disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
493,I15,(secondary hypertension),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
494,I20,(angina pectoris),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
495,I21,(acute myocardial infarction),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
496,I22,(subsequent myocardial infarction),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
497,I23,(certain current complications following acute myocardial infarction),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
498,I24,(other acute ischaemic heart diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
499,I25,(chronic ischaemic heart disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
500,I26,(pulmonary embolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
501,I27,(other pulmonary heart diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
502,I28,(other diseases of pulmonary vessels),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
503,I30,(acute pericarditis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
504,I31,(other diseases of pericardium),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
505,I32,(pericarditis in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
506,I33,(acute and subacute endocarditis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
507,I34,(nonrheumatic mitral valve disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
508,I35,(nonrheumatic aortic valve disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
509,I36,(nonrheumatic tricuspid valve disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
510,I37,(pulmonary valve disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
511,I38,"(endocarditis, valve unspecified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
512,I39,(endocarditis and heart valve disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
513,I40,(acute myocarditis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
514,I41,(myocarditis in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
515,I42,(cardiomyopathy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
516,I43,(cardiomyopathy in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
517,I44,(atrioventricular and left bundle-branch block),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
518,I45,(other conduction disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
519,I46,(cardiac arrest),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
520,I47,(paroxysmal tachycardia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
521,I48,(atrial fibrillation and flutter),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
522,I49,(other cardiac arrhythmias),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
523,I50,(heart failure),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
524,I51,(complications and ill-defined descriptions of heart disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
525,I52,(other heart disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
526,I60,(subarachnoid haemorrhage),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
527,I61,(intracerebral haemorrhage),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
528,I62,(other nontraumatic intracranial haemorrhage),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
529,I63,(cerebral infarction),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.8,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
530,I64,"(stroke, not specified as haemorrhage or infarction)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
531,I65,"(occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
532,I66,"(occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
533,I67,(other cerebrovascular diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,2.6,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
534,I68,(cerebrovascular disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
535,I69,(sequelae of cerebrovascular disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,3.7,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
536,I70,(atherosclerosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
537,I71,(aortic aneurysm and dissection),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
538,I72,(other aneurysm),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
539,I73,(other peripheral vascular diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
540,I74,(arterial embolism and thrombosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
541,I77,(other disorders of arteries and arterioles),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
542,I78,(diseases of capillaries),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
543,I79,"(disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
544,I80,(phlebitis and thrombophlebitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
545,I81,(portal vein thrombosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
546,I82,(other venous embolism and thrombosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
547,I83,(varicose veins of lower extremities),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
548,I84,(haemorrhoids),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
549,I85,(oesophageal varices),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
550,I86,(varicose veins of other sites),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
551,I87,(other disorders of veins),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
552,I88,(nonspecific lymphadenitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
553,I89,(other non-infective disorders of lymphatic vessels and lymph nodes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
554,I95,(hypotension),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.6,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
555,I97,"(postprocedural disorders of circulatory system, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
556,I98,(other disorders of circulatory system in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
557,I99,(other and unspecified disorders of circulatory system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
558,J00,(acute nasopharyngitis [common cold]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
559,J01,(acute sinusitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
560,J02,(acute pharyngitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
561,J03,(acute tonsillitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
562,J04,(acute laryngitis and tracheitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
563,J05,(acute obstructive laryngitis [croup] and epiglottitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
564,J06,(acute upper respiratory infections of multiple and unspecified sites),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
565,J09,(influenza due to certain identified influenza virus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
566,J10,(influenza due to identified influenza virus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
567,J11,"(influenza, virus not identified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
568,J12,"(viral pneumonia, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
569,J13,(pneumonia due to streptococcus pneumoniae),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
570,J14,(pneumonia due to haemophilus influenzae),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
571,J15,"(bacterial pneumonia, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
572,J16,"(pneumonia due to other infectious organisms, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
573,J17,(pneumonia in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
574,J18,"(pneumonia, organism unspecified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.1,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
575,J20,(acute bronchitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
576,J21,(acute bronchiolitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
577,J22,(unspecified acute lower respiratory infection),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.7,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
578,J30,(vasomotor and allergic rhinitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
579,J31,"(chronic rhinitis, nasopharyngitis and pharyngitis)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
580,J32,(chronic sinusitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
581,J33,(nasal polyp),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
582,J34,(other disorders of nose and nasal sinuses),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
583,J35,(chronic diseases of tonsils and adenoids),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
584,J36,(peritonsillar abscess),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
585,J37,(chronic laryngitis and laryngotracheitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
586,J38,"(diseases of vocal cords and larynx, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
587,J39,(other diseases of upper respiratory tract),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
588,J40,"(bronchitis, not specified as acute or chronic)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
589,J41,(simple and mucopurulent chronic bronchitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
590,J42,(unspecified chronic bronchitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
591,J43,(emphysema),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
592,J44,(other chronic obstructive pulmonary disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
593,J45,(asthma),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
594,J46,(status asthmaticus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
595,J47,(bronchiectasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
596,J60,(coalworker's pneumoconiosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
597,J61,(pneumoconiosis due to asbestos and other mineral fibres),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
598,J62,(pneumoconiosis due to dust containing silica),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
599,J63,(pneumoconiosis due to other inorganic dusts),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
600,J64,(unspecified pneumoconiosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
601,J66,(airway disease due to specific organic dust),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
602,J67,(hypersensitivity pneumonitis due to organic dust),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
603,J68,"(respiratory conditions due to inhalation of chemicals, gases, fumes and vapours)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
604,J69,(pneumonitis due to solids and liquids),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
605,J70,(respiratory conditions due to other external agents),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
606,J80,(adult respiratory distress syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
607,J81,(pulmonary oedema),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
608,J82,"(pulmonary eosinophilia, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
609,J84,(other interstitial pulmonary diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
610,J85,(abscess of lung and mediastinum),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
611,J86,(pyothorax),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
612,J90,"(pleural effusion, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
613,J91,(pleural effusion in conditions classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
614,J92,(pleural plaque),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
615,J93,(pneumothorax),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
616,J94,(other pleural conditions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
617,J95,"(postprocedural respiratory disorders, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
618,J96,"(respiratory failure, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.5,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
619,J98,(other respiratory disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
620,J99,(respiratory disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
621,K00,(disorders of tooth development and eruption),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
622,K01,(embedded and impacted teeth),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
623,K02,(dental caries),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
624,K03,(other diseases of hard tissues of teeth),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
625,K04,(diseases of pulp and periapical tissues),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
626,K05,(gingivitis and periodontal diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
627,K06,(other disorders of gingiva and edentulous alveolar ridge),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
628,K07,(dentofacial anomalies [including malocclusion]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
629,K08,(other disorders of teeth and supporting structures),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
630,K09,"(cysts of oral region, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
631,K10,(other diseases of jaws),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
632,K11,(diseases of salivary glands),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
633,K12,(stomatitis and related lesions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
634,K13,(other diseases of lip and oral mucosa),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
635,K14,(diseases of tongue),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
636,K20,(oesophagitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
637,K21,(gastro-oesophageal reflux disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
638,K22,(other diseases of oesophagus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
639,K23,(disorders of oesophagus in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
640,K25,(gastric ulcer),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
641,K26,(duodenal ulcer),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.6,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
642,K27,"(peptic ulcer, site unspecified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
643,K28,(gastrojejunal ulcer),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
644,K29,(gastritis and duodenitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
645,K30,(dyspepsia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
646,K31,(other diseases of stomach and duodenum),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
647,K35,(acute appendicitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
648,K36,(other appendicitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
649,K37,(unspecified appendicitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
650,K38,(other diseases of appendix),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
651,K40,(inguinal hernia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
652,K41,(femoral hernia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
653,K42,(umbilical hernia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
654,K43,(ventral hernia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
655,K44,(diaphragmatic hernia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
656,K45,(other abdominal hernia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
657,K46,(unspecified abdominal hernia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
658,K50,(crohn's disease [regional enteritis]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
659,K51,(ulcerative colitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
660,K52,(other non-infective gastro-enteritis and colitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.3,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
661,K55,(vascular disorders of intestine),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
662,K56,(paralytic ileus and intestinal obstruction without hernia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
663,K57,(diverticular disease of intestine),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
664,K58,(irritable bowel syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
665,K59,(other functional intestinal disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.8,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
666,K60,(fissure and fistula of anal and rectal regions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
667,K61,(abscess of anal and rectal regions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
668,K62,(other diseases of anus and rectum),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
669,K63,(other diseases of intestine),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
670,K64,(haemorrhoids and perianal venous thrombosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
671,K65,(peritonitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
672,K66,(other disorders of peritoneum),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
673,K67,(disorders of peritoneum in infectious diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
674,K70,(alcoholic liver disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
675,K71,(toxic liver disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
676,K72,"(hepatic failure, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
677,K73,"(chronic hepatitis, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
678,K74,(fibrosis and cirrhosis of liver),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
679,K75,(other inflammatory liver diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
680,K76,(other diseases of liver),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
681,K77,(liver disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
682,K80,(cholelithiasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
683,K81,(cholecystitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
684,K82,(other diseases of gallbladder),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
685,K83,(other diseases of biliary tract),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
686,K85,(acute pancreatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
687,K86,(other diseases of pancreas),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
688,K87,"(disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
689,K90,(intestinal malabsorption),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
690,K91,"(postprocedural disorders of digestive system, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
691,K92,(other diseases of digestive system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.8,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
692,K93,(disorders of other digestive organs in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
693,L00,(staphylococcal scalded skin syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
694,L01,(impetigo),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
695,L02,"(cutaneous abscess, furuncle and carbuncle)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
696,L03,(cellulitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,2.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
697,L04,(acute lymphadenitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
698,L05,(pilonidal cyst),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
699,L08,(other local infections of skin and subcutaneous tissue),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.4,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
700,L10,(pemphigus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
701,L11,(other acantholytic disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
702,L12,(pemphigoid),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
703,L13,(other bullous disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
704,L14,(bullous disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
705,L20,(atopic dermatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
706,L21,(seborrhoeic dermatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
707,L22,(diaper [napkin] dermatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
708,L23,(allergic contact dermatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
709,L24,(irritant contact dermatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
710,L25,(unspecified contact dermatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
711,L26,(exfoliative dermatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
712,L27,(dermatitis due to substances taken internally),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
713,L28,(lichen simplex chronicus and prurigo),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
714,L29,(pruritus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
715,L30,(other dermatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
716,L40,(psoriasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
717,L41,(parapsoriasis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
718,L42,(pityriasis rosea),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
719,L43,(lichen planus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
720,L44,(other papulosquamous disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
721,L50,(urticaria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
722,L51,(erythema multiforme),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
723,L52,(erythema nodosum),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
724,L53,(other erythematous conditions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
725,L54,(erythema in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
726,L55,(sunburn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
727,L56,(other acute skin changes due to ultraviolet radiation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
728,L57,(skin changes due to chronic exposure to nonionising radiation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
729,L58,(radiodermatitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
730,L59,(other disorders of skin and subcutaneous tissue related to radiation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
731,L60,(nail disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
732,L62,(nail disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
733,L63,(alopecia areata),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
734,L64,(androgenic alopecia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
735,L65,(other nonscarring hair loss),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
736,L66,(cicatricial alopecia [scarring hair loss]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
737,L67,(hair colour and hair shaft abnormalities),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
738,L68,(hypertrichosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
739,L70,(acne),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
740,L71,(rosacea),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
741,L72,(follicular cysts of skin and subcutaneous tissue),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
742,L73,(other follicular disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
743,L74,(eccrine sweat disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
744,L75,(apocrine sweat disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
745,L80,(vitiligo),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
746,L81,(other disorders of pigmentation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
747,L82,(seborrhoeic keratosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
748,L83,(acanthosis nigricans),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
749,L84,(corns and callosities),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
750,L85,(other epidermal thickening),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
751,L86,(keratoderma in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
752,L87,(transepidermal elimination disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
753,L88,(pyoderma gangrenosum),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
754,L89,(decubitus ulcer),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.7,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
755,L90,(atrophic disorders of skin),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
756,L91,(hypertrophic disorders of skin),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
757,L92,(granulomatous disorders of skin and subcutaneous tissue),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
758,L93,(lupus erythematosus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
759,L94,(other localised connective tissue disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
760,L95,"(vasculitis limited to skin, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
761,L97,"(ulcer of lower limb, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.6,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
762,L98,"(other disorders of skin and subcutaneous tissue, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
763,L99,(other disorders of skin and subcutaneous tissue in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
764,M00,(pyogenic arthritis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
765,M01,(direct infections of joint in infectious and parasitic diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
766,M02,(reactive arthropathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
767,M03,(postinfective and reactive arthropathies in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
768,M05,(seropositive rheumatoid arthritis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
769,M06,(other rheumatoid arthritis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
770,M07,(psoriatic and enteropathic arthropathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
771,M08,(juvenile arthritis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
772,M09,(juvenile arthritis in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
773,M10,(gout),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
774,M11,(other crystal arthropathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
775,M12,(other specific arthropathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
776,M13,(other arthritis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
777,M14,(arthropathies in other diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
778,M15,(polyarthrosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.4,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
779,M16,(coxarthrosis [arthrosis of hip]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
780,M17,(gonarthrosis [arthrosis of knee]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
781,M18,(arthrosis of first carpometacarpal joint),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
782,M19,(other arthrosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.5,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
783,M20,(acquired deformities of fingers and toes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
784,M21,(other acquired deformities of limbs),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
785,M22,(disorders of patella),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
786,M23,(internal derangement of knee),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
787,M24,(other specific joint derangements),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
788,M25,"(other joint disorders, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,2.3,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
789,M30,(polyarteritis nodosa and related conditions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
790,M31,(other necrotising vasculopathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
791,M32,(systemic lupus erythematosus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
792,M33,(dermatopolymyositis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
793,M34,(systemic sclerosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
794,M35,(other systemic involvement of connective tissue),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
795,M36,(systemic disorders of connective tissue in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
796,M40,(kyphosis and lordosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
797,M41,(scoliosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.9,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
798,M42,(spinal osteochondrosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
799,M43,(other deforming dorsopathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
800,M45,(ankylosing spondylitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
801,M46,(other inflammatory spondylopathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
802,M47,(spondylosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
803,M48,(other spondylopathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.5,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
804,M49,(spondylopathies in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
805,M50,(cervical disk disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
806,M51,(other intervertebral disk disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
807,M53,"(other dorsopathies, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
808,M54,(dorsalgia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
809,M60,(myositis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
810,M61,(calcification and ossification of muscle),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
811,M62,(other disorders of muscle),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
812,M63,(disorders of muscle in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
813,M65,(synovitis and tenosynovitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
814,M66,(spontaneous rupture of synovium and tendon),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
815,M67,(other disorders of synovium and tendon),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
816,M68,(disorders of synovium and tendon in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
817,M70,"(soft tissue disorders related to use, overuse and pressure)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
818,M71,(other bursopathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
819,M72,(fibroblastic disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
820,M73,(soft tissue disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
821,M75,(shoulder lesions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
822,M76,"(enthesopathies of lower limb, excluding foot)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
823,M77,(other enthesopathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
824,M79,"(other soft tissue disorders, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.1,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
825,M80,(osteoporosis with pathological fracture),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.8,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
826,M81,(osteoporosis without pathological fracture),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.4,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
827,M82,(osteoporosis in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
828,M83,(adult osteomalacia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
829,M84,(disorders of continuity of bone),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
830,M85,(other disorders of bone density and structure),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
831,M86,(osteomyelitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
832,M87,(osteonecrosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
833,M88,(paget's disease of bone [osteitis deformans]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
834,M89,(other disorders of bone),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
835,M90,(osteopathies in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
836,M91,(juvenile osteochondrosis of hip and pelvis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
837,M92,(other juvenile osteochondrosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
838,M93,(other osteochondropathies),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
839,M94,(other disorders of cartilage),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
840,M95,(other acquired deformities of musculoskeletal system and connective tissue),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
841,M96,"(postprocedural musculoskeletal disorders, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
842,M99,"(biomechanical lesions, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
843,N00,(acute nephritic syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
844,N01,(rapidly progressive nephritic syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
845,N02,(recurrent and persistent haematuria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
846,N03,(chronic nephritic syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
847,N04,(nephrotic syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
848,N05,(unspecified nephritic syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
849,N06,(isolated proteinuria with specified morphological lesion),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
850,N07,"(hereditary nephropathy, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
851,N08,(glomerular disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
852,N10,(acute tubulo-interstitial nephritis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
853,N11,(chronic tubulo-interstitial nephritis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
854,N12,"(tubulo-interstitial nephritis, not specified as acute or chronic)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
855,N13,(obstructive and reflux uropathy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
856,N14,(drug- and heavy-metal-induced tubulo-interstitial and tubular conditions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
857,N15,(other renal tubulo-interstitial diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
858,N16,(renal tubulo-interstitial disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
859,N17,(acute renal failure),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.8,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
860,N18,(chronic renal failure),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.4,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
861,N19,(unspecified renal failure),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.6,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
862,N20,(calculus of kidney and ureter),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.7,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
863,N21,(calculus of lower urinary tract),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
864,N22,(calculus of urinary tract in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
865,N23,(unspecified renal colic),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
866,N25,(disorders resulting from impaired renal tubular function),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
867,N26,(unspecified contracted kidney),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
868,N27,(small kidney of unknown cause),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
869,N28,"(other disorders of kidney and ureter, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,1.3,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
870,N29,(other disorders of kidney and ureter in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
871,N30,(cystitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
872,N31,"(neuromuscular dysfunction of bladder, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
873,N32,(other disorders of bladder),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
874,N33,(bladder disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
875,N34,(urethritis and urethral syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
876,N35,(urethral stricture),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
877,N36,(other disorders of urethra),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
878,N37,(urethral disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
879,N39,(other disorders of urinary system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,3.2,Gilbert et al. Lancet 2018 supplementary appendix Table A2,exact_three_character_icd10
|
||
|
|
880,N40,(hyperplasia of prostate),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
881,N41,(inflammatory diseases of prostate),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
882,N42,(other disorders of prostate),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
883,N43,(hydrocele and spermatocele),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
884,N44,(torsion of testis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
885,N45,(orchitis and epididymitis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
886,N46,(male infertility),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
887,N47,"(redundant prepuce, phimosis and paraphimosis)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
888,N48,(other disorders of penis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
889,N49,"(inflammatory disorders of male genital organs, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
890,N50,(other disorders of male genital organs),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
891,N51,(disorders of male genital organs in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
892,N60,(benign mammary dysplasia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
893,N61,(inflammatory disorders of breast),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
894,N62,(hypertrophy of breast),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
895,N63,(unspecified lump in breast),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
896,N64,(other disorders of breast),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
897,N70,(salpingitis and oophoritis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
898,N71,"(inflammatory disease of uterus, except cervix)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
899,N72,(inflammatory disease of cervix uteri),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
900,N73,(other female pelvic inflammatory diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
901,N74,(female pelvic inflammatory disorders in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
902,N75,(diseases of bartholin's gland),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
903,N76,(other inflammation of vagina and vulva),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
904,N77,(vulvovaginal ulceration and inflammation in diseases classified elsewhere),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
905,N80,(endometriosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
906,N81,(female genital prolapse),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
907,N82,(fistulae involving female genital tract),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
908,N83,"(noninflammatory disorders of ovary, fallopian tube and broad ligament)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
909,N84,(polyp of female genital tract),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
910,N85,"(other noninflammatory disorders of uterus, except cervix)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
911,N86,(erosion and ectropion of cervix uteri),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
912,N87,(dysplasia of cervix uteri),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
913,N88,(other noninflammatory disorders of cervix uteri),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
914,N89,(other noninflammatory disorders of vagina),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
915,N90,(other noninflammatory disorders of vulva and perineum),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
916,N91,"(absent, scanty and rare menstruation)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
917,N92,"(excessive, frequent and irregular menstruation)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
918,N93,(other abnormal uterine and vaginal bleeding),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
919,N94,(pain and other conditions associated with female genital organs and menstrual cycle),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
920,N95,(menopausal and other perimenopausal disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
921,N96,(habitual aborter),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
922,N97,(female infertility),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
923,N98,(complications associated with artificial fertilisation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
924,N99,"(postprocedural disorders of genito-urinary system, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
925,O00,(ectopic pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
926,O01,(hydatidiform mole),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
927,O02,(other abnormal products of conception),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
928,O03,(spontaneous abortion),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
929,O04,(medical abortion),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
930,O05,(other abortion),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
931,O06,(unspecified abortion),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
932,O07,(failed attempted abortion),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
933,O08,(complications following abortion and ectopic and molar pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
934,O10,"(pre-existing hypertension complicating pregnancy, childbirth and the puerperium)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
935,O11,(pre-existing hypertensive disorder with superimposed proteinuria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
936,O12,(gestational [pregnancy-induced] oedema and proteinuria without hypertension),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
937,O13,(gestational [pregnancy-induced] hypertension without significant proteinuria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
938,O14,(gestational [pregnancy-induced] hypertension with significant proteinuria),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
939,O15,(eclampsia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
940,O16,(unspecified maternal hypertension),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
941,O20,(haemorrhage in early pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
942,O21,(excessive vomiting in pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
943,O22,(venous complications in pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
944,O23,(infections of genito-urinary tract in pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
945,O24,(diabetes mellitus in pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
946,O25,(malnutrition in pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
947,O26,(maternal care for other conditions predominantly related to pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
948,O28,(abnormal findings on antenatal screening of mother),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
949,O29,(complications of anaesthesia during pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
950,O30,(multiple gestation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
951,O31,(complications specific to multiple gestation),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
952,O32,(maternal care for known or suspected malpresentation of foetus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
953,O33,(maternal care for known or suspected disproportion),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
954,O34,(maternal care for known or suspected abnormality of pelvic organs),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
955,O35,(maternal care for known or suspected foetal abnormality and damage),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
956,O36,(maternal care for other known or suspected foetal problems),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
957,O40,(polyhydramnios),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
958,O41,(other disorders of amniotic fluid and membranes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
959,O42,(premature rupture of membranes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
960,O43,(placental disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
961,O44,(placenta praevia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
962,O45,(premature separation of placenta [abruptio placentae]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
963,O46,"(antepartum haemorrhage, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
964,O47,(false labour),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
965,O48,(prolonged pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
966,O60,(preterm delivery),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
967,O61,(failed induction of labour),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
968,O62,(abnormalities of forces of labour),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
969,O63,(long labour),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
970,O64,(obstructed labour due to malposition and malpresentation of foetus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
971,O65,(obstructed labour due to maternal pelvic abnormality),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
972,O66,(other obstructed labour),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
973,O67,"(labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
974,O68,(labour and delivery complicated by foetal stress [distress]),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
975,O69,(labour and delivery complicated by umbilical cord complications),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
976,O70,(perineal laceration during delivery),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
977,O71,(other obstetric trauma),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
978,O72,(postpartum haemorrhage),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
979,O73,"(retained placenta and membranes, without haemorrhage)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
980,O74,(complications of anaesthesia during labour and delivery),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
981,O75,"(other complications of labour and delivery, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
982,O80,(single spontaneous delivery),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
983,O81,(single delivery by forceps and vacuum extractor),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
984,O82,(single delivery by caesarean section),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
985,O83,(other assisted single delivery),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
986,O84,(multiple delivery),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
987,O85,(puerperal sepsis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
988,O86,(other puerperal infections),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
989,O87,(venous complications in the puerperium),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
990,O88,(obstetric embolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
991,O89,(complications of anaesthesia during the puerperium),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
992,O90,"(complications of the puerperium, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
993,O91,(infections of breast associated with childbirth),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
994,O92,(other disorders of breast and lactation associated with childbirth),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
995,O94,"(sequelae of complication of pregnancy, childbirth and the puerperium)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
996,O96,(death from any obstetric cause occurring more than 42 days but less than one year after delivery),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
997,O98,"(maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
998,O99,"(other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
999,P00,(foetus and newborn affected by maternal conditions that may be unrelated to present pregnancy),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1000,P02,"(foetus and newborn affected by complications of placenta, cord and membranes)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1001,P03,(foetus and newborn affected by other complications of labour and delivery),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1002,P04,(foetus and newborn affected by noxious influences transmitted via placenta or breast milk),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1003,P05,(slow foetal growth and foetal malnutrition),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1004,P07,"(disorders related to short gestation and low birth weight, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1005,P08,(disorders related to long gestation and high birth weight),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1006,P10,(intracranial laceration and haemorrhage due to birth injury),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1007,P11,(other birth injuries to central nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1008,P12,(birth injury to scalp),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1009,P13,(birth injury to skeleton),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1010,P14,(birth injury to peripheral nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1011,P15,(other birth injuries),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1012,P20,(intra-uterine hypoxia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1013,P21,(birth asphyxia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1014,P22,(respiratory distress of newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1015,P23,(congenital pneumonia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1016,P24,(neonatal aspiration syndromes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1017,P25,(interstitial emphysema and related conditions originating in the perinatal period),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1018,P26,(pulmonary haemorrhage originating in the perinatal period),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1019,P27,(chronic respiratory disease originating in the perinatal period),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1020,P28,(other respiratory conditions originating in the perinatal period),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1021,P29,(cardiovascular disorders originating in the perinatal period),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1022,P35,(congenital viral diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1023,P36,(bacterial sepsis of newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1024,P37,(other congenital infectious and parasitic diseases),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1025,P38,(omphalitis of newborn with or without mild haemorrhage),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1026,P39,(other infections specific to the perinatal period),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1027,P50,(foetal blood loss),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1028,P51,(umbilical haemorrhage of newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1029,P52,(intracranial nontraumatic haemorrhage of foetus and newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1030,P53,(haemorrhagic disease of foetus and newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1031,P54,(other neonatal haemorrhages),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1032,P55,(haemolytic disease of foetus and newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1033,P58,(neonatal jaundice due to other excessive haemolysis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1034,P59,(neonatal jaundice from other and unspecified causes),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1035,P61,(other perinatal haematological disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1036,P70,(transitory disorders of carbohydrate metabolism specific to foetus and newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1037,P71,(transitory neonatal disorders of calcium and magnesium metabolism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1038,P78,(other perinatal digestive system disorders),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1039,P83,(other conditions of integument specific to foetus and newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1040,P91,(other disturbances of cerebral status of newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1041,P92,(feeding problems of newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1042,P94,(disorders of muscle tone of newborn),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1043,P95,(foetal death of unspecified cause),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1044,P96,(other conditions originating in the perinatal period),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1045,Q00,(anencephaly and similar malformations),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1046,Q01,(encephalocele),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1047,Q02,(microcephaly),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1048,Q03,(congenital hydrocephalus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1049,Q04,(other congenital malformations of brain),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1050,Q05,(spina bifida),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1051,Q06,(other congenital malformations of spinal cord),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1052,Q07,(other congenital malformations of nervous system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1053,Q10,"(congenital malformations of eyelid, lachrymal apparatus and orbit)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1054,Q11,"(anophthalmos, microphthalmos and macrophthalmos)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1055,Q12,(congenital lens malformations),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1056,Q13,(congenital malformations of anterior segment of eye),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1057,Q14,(congenital malformations of posterior segment of eye),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1058,Q15,(other congenital malformations of eye),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1059,Q16,(congenital malformations of ear causing impairment of hearing),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1060,Q17,(other congenital malformations of ear),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1061,Q18,(other congenital malformations of face and neck),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1062,Q20,(congenital malformations of cardiac chambers and connexions),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1063,Q21,(congenital malformations of cardiac septa),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1064,Q22,(congenital malformations of pulmonary and tricuspid valves),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1065,Q23,(congenital malformations of aortic and mitral valves),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1066,Q24,(other congenital malformations of heart),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1067,Q25,(congenital malformations of great arteries),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1068,Q26,(congenital malformations of great veins),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1069,Q27,(other congenital malformations of peripheral vascular system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1070,Q28,(other congenital malformations of circulatory system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1071,Q30,(congenital malformations of nose),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1072,Q31,(congenital malformations of larynx),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1073,Q32,(congenital malformations of trachea and bronchus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1074,Q33,(congenital malformations of lung),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1075,Q34,(other congenital malformations of respiratory system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1076,Q35,(cleft palate),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1077,Q36,(cleft lip),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1078,Q37,(cleft palate with cleft lip),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1079,Q38,"(other congenital malformations of tongue, mouth and pharynx)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1080,Q39,(congenital malformations of oesophagus),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1081,Q40,(other congenital malformations of upper alimentary tract),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1082,Q41,"(congenital absence, atresia and stenosis of small intestine)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1083,Q42,"(congenital absence, atresia and stenosis of large intestine)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1084,Q43,(other congenital malformations of intestine),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1085,Q44,"(congenital malformations of gallbladder, bile ducts and liver)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1086,Q45,(other congenital malformations of digestive system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1087,Q50,"(congenital malformations of ovaries, fallopian tubes and broad ligaments)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1088,Q51,(congenital malformations of uterus and cervix),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1089,Q52,(other congenital malformations of female genitalia),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1090,Q53,(undescended testicle),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1091,Q54,(hypospadias),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1092,Q55,(other congenital malformations of male genital organs),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1093,Q56,(indeterminate sex and pseudohermaphroditism),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1094,Q60,(renal agenesis and other reduction defects of kidney),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1095,Q61,(cystic kidney disease),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1096,Q62,(congenital obstructive defects of renal pelvis and congenital malformations of ureter),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1097,Q63,(other congenital malformations of kidney),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1098,Q64,(other congenital malformations of urinary system),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1099,Q65,(congenital deformities of hip),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1100,Q66,(congenital deformities of feet),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1101,Q67,"(congenital musculoskeletal deformities of head, face, spine and chest)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1102,Q68,(other congenital musculoskeletal deformities),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1103,Q69,(polydactyly),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1104,Q70,(syndactyly),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1105,Q71,(reduction defects of upper limb),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1106,Q72,(reduction defects of lower limb),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1107,Q73,(reduction defects of unspecified limb),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1108,Q74,(other congenital malformations of limb(s)),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1109,Q75,(other congenital malformations of skull and face bones),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1110,Q76,(congenital malformations of spine and bony thorax),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1111,Q77,(osteochondrodysplasia with defects of growth of tubular bones and spine),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1112,Q78,(other osteochondrodysplasias),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1113,Q79,"(congenital malformations of musculoskeletal system, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1114,Q80,(congenital ichthyosis),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1115,Q81,(epidermolysis bullosa),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1116,Q82,(other congenital malformations of skin),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1117,Q83,(congenital malformations of breast),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1118,Q84,(other congenital malformations of integument),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1119,Q85,"(phakomatoses, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1120,Q86,"(congenital malformation syndromes due to known exogenous causes, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1121,Q87,(other specified congenital malformation syndromes affecting multiple systems),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1122,Q89,"(other congenital malformations, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1123,Q90,(down's syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1124,Q91,(edwards' syndrome and patau's syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1125,Q92,"(other trisomies and partial trisomies of the autosomes, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1126,Q93,"(monosomies and deletions from the autosomes, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1127,Q95,"(balanced rearrangements and structural markers, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1128,Q96,(turner's syndrome),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1129,Q97,"(other sex chromosome abnormalities, female phenotype, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1130,Q98,"(other sex chromosome abnormalities, male phenotype, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1131,Q99,"(other chromosome abnormalities, not elsewhere classified)",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1132,CXX,Unknown Cancer,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1133,C00,Malignant neoplasm of lip,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1134,C01,Malignant neoplasm of base of tongue,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1135,C02,Malignant neoplasm of other and unspecified parts of tongue,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1136,C03,Malignant neoplasm of gum,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1137,C04,Malignant neoplasm of floor of mouth,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1138,C05,Malignant neoplasm of palate,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1139,C06,Malignant neoplasm of other and unspecified parts of mouth,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1140,C07,Malignant neoplasm of parotid gland,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1141,C08,Malignant neoplasm of other and unspecified major salivary glands,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1142,C09,Malignant neoplasm of tonsil,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1143,C10,Malignant neoplasm of oropharynx,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1144,C11,Malignant neoplasm of nasopharynx,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1145,C12,Malignant neoplasm of pyriform sinus,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1146,C13,Malignant neoplasm of hypopharynx,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1147,C14,"Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1148,C15,Malignant neoplasm of oesophagus,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1149,C16,Malignant neoplasm of stomach,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1150,C17,Malignant neoplasm of small intestine,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1151,C18,Malignant neoplasm of colon,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1152,C19,Malignant neoplasm of rectosigmoid junction,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1153,C20,Malignant neoplasm of rectum,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1154,C21,Malignant neoplasm of anus and anal canal,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1155,C22,Malignant neoplasm of liver and intrahepatic bile ducts,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1156,C23,Malignant neoplasm of gallbladder,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1157,C24,Malignant neoplasm of other and unspecified parts of biliary tract,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1158,C25,Malignant neoplasm of pancreas,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1159,C26,Malignant neoplasm of other and ill-defined digestive organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1160,C30,Malignant neoplasm of nasal cavity and middle ear,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1161,C31,Malignant neoplasm of accessory sinuses,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1162,C32,Malignant neoplasm of larynx,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1163,C33,Malignant neoplasm of trachea,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1164,C34,Malignant neoplasm of bronchus and lung,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1165,C37,Malignant neoplasm of thymus,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1166,C38,"Malignant neoplasm of heart, mediastinum and pleura",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1167,C39,Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1168,C40,Malignant neoplasm of bone and articular cartilage of limbs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1169,C41,Malignant neoplasm of bone and articular cartilage of other and unspecified sites,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1170,C42,hematopoietic and reticuloendothelial systems (ICD-O-3 specific),hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1171,C43,Malignant melanoma of skin,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1172,C44,Other malignant neoplasms of skin,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1173,C45,Mesothelioma,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1174,C46,Kaposi's sarcoma,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1175,C47,Malignant neoplasm of peripheral nerves and autonomic nervous system,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1176,C48,Malignant neoplasm of retroperitoneum and peritoneum,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1177,C49,Malignant neoplasm of other connective and soft tissue,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1178,C50,Malignant neoplasm of breast,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1179,C51,Malignant neoplasm of vulva,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1180,C52,Malignant neoplasm of vagina,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1181,C53,Malignant neoplasm of cervix uteri,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1182,C54,Malignant neoplasm of corpus uteri,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1183,C55,"Malignant neoplasm of uterus, part unspecified",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1184,C56,Malignant neoplasm of ovary,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1185,C57,Malignant neoplasm of other and unspecified female genital organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1186,C58,Malignant neoplasm of placenta,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1187,C60,Malignant neoplasm of penis,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1188,C61,Malignant neoplasm of prostate,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1189,C62,Malignant neoplasm of testis,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1190,C63,Malignant neoplasm of other and unspecified male genital organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1191,C64,"Malignant neoplasm of kidney, except renal pelvis",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1192,C65,Malignant neoplasm of renal pelvis,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1193,C66,Malignant neoplasm of ureter,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1194,C67,Malignant neoplasm of bladder,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1195,C68,Malignant neoplasm of other and unspecified urinary organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1196,C69,Malignant neoplasm of eye and adnexa,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1197,C70,Malignant neoplasm of meninges,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1198,C71,Malignant neoplasm of brain,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1199,C72,"Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1200,C73,Malignant neoplasm of thyroid gland,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1201,C74,Malignant neoplasm of adrenal gland,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1202,C75,Malignant neoplasm of other endocrine glands and related structures,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1203,C76,Malignant neoplasm of other and ill-defined sites,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1204,C77,Secondary and unspecified malignant neoplasm of lymph nodes,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1205,C78,Secondary malignant neoplasm of respiratory and digestive organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1206,C79,Secondary malignant neoplasm of other sites,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1207,C80,Malignant neoplasm without specification of site,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1208,C81,Hodgkin's disease,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1209,C82,Follicular [nodular] non-Hodgkin's lymphoma,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1210,C83,Diffuse non-Hodgkin's lymphoma,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1211,C84,Peripheral and cutaneous T-cell lymphomas,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1212,C85,Other and unspecified types of non-Hodgkin's lymphoma,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1213,C86,Other specified types of T/NK-cell lymphoma,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1214,C88,Malignant immunoproliferative diseases,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1215,C90,Multiple myeloma and malignant plasma cell neoplasms,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1216,C91,Lymphoid leukaemia,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1217,C92,Myeloid leukaemia,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1218,C93,Monocytic leukaemia,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1219,C94,Other leukaemias of specified cell type,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1220,C95,Leukaemia of unspecified cell type,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1221,C96,"Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1222,C97,Malignant neoplasms of independent (primary) multiple sites,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1223,D00,"Carcinoma in situ of oral cavity, oesophagus and stomach",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1224,D01,Carcinoma in situ of other and unspecified digestive organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1225,D02,Carcinoma in situ of middle ear and respiratory system,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1226,D03,Melanoma in situ,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1227,D04,Carcinoma in situ of skin,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1228,D05,Carcinoma in situ of breast,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1229,D06,Carcinoma in situ of cervix uteri,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1230,D07,Carcinoma in situ of other and unspecified genital organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1231,D09,Carcinoma in situ of other and unspecified sites,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1232,D10,Benign neoplasm of mouth and pharynx,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1233,D11,Benign neoplasm of major salivary glands,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1234,D12,"Benign neoplasm of colon, rectum, anus and anal canal",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1235,D13,Benign neoplasm of other and ill-defined parts of digestive system,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1236,D15,Benign neoplasm of other and unspecified intrathoracic organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1237,D16,Benign neoplasm of bone and articular cartilage,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1238,D18,"Haemangioma and lymphangioma, any site",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1239,D27,Benign neoplasm of ovary,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1240,D30,Benign neoplasm of urinary organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1241,D32,Benign neoplasm of meninges,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1242,D33,Benign neoplasm of brain and other parts of central nervous system,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1243,D34,Benign neoplasm of thyroid gland,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1244,D35,Benign neoplasm of other and unspecified endocrine glands,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1245,D36,Benign neoplasm of other and unspecified sites,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1246,D37,Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1247,D38,Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1248,D39,Neoplasm of uncertain or unknown behaviour of female genital organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1249,D40,Neoplasm of uncertain or unknown behaviour of male genital organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1250,D41,Neoplasm of uncertain or unknown behaviour of urinary organs,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1251,D42,Neoplasm of uncertain or unknown behaviour of meninges,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1252,D43,Neoplasm of uncertain or unknown behaviour of brain and central nervous system,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1253,D44,Neoplasm of uncertain or unknown behaviour of endocrine glands,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1254,D45,Polycythaemia vera,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1255,D46,Myelodysplastic syndromes,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1256,D47,"Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1257,D48,Neoplasm of uncertain or unknown behaviour of other and unspecified sites,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|
||
|
|
1258,DEATH,,hfrs_weighted_disease_expression,DeepHealth HFRS-weighted disease expression,UK-HFRS,0.0,Gilbert et al. Lancet 2018 supplementary appendix Table A2,not_in_hfrs
|